These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12948053)

  • 1. Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France.
    Baudouin C; Rouland JF; Le Pen C
    Eur J Ophthalmol; 2003 Jul; 13 Suppl 4():S53-60. PubMed ID: 12948053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in medical and surgical treatments of glaucoma between 1997 and 2003 in France.
    Kenigsberg PA
    Eur J Ophthalmol; 2007; 17(4):521-7. PubMed ID: 17671925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies.
    Strutton DR; Walt JG
    J Glaucoma; 2004 Jun; 13(3):221-6. PubMed ID: 15118466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
    Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
    Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P
    Arch Ophthalmol; 2003 Apr; 121(4):453-7. PubMed ID: 12695241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed-combination brimonidine/timolol as adjunctive therapy to a prostaglandin analog: a 3-month, open-label, replacement study in glaucoma patients.
    Nguyen QH; Earl M
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):541-4. PubMed ID: 20028261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.
    Goldberg LD; Walt J
    Pharmacoeconomics; 2006; 24(3):251-64. PubMed ID: 16519547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: strategies, clinical outcomes, and costs at 1 year.
    Rouland JF; Le Pen C;
    Eur J Ophthalmol; 2003 Jul; 13 Suppl 4():S5-20. PubMed ID: 12948049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
    Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research Database.
    Lafuma A; Berdeaux G
    Curr Med Res Opin; 2007 Dec; 23(12):3009-16. PubMed ID: 17958945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination.
    Akman A; Cetinkaya A; Akova YA; Ertan A
    Eye (Lond); 2005 Feb; 19(2):145-51. PubMed ID: 15184958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
    Nordmann JP; Söderström M; Rouland JF; Malecaze F
    Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.
    Parmaksiz S; Yüksel N; Karabas VL; Ozkan B; Demirci G; Caglar Y
    Eur J Ophthalmol; 2006; 16(1):73-80. PubMed ID: 16496249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of a nationwide introduction of new drugs and a treatment protocol for glaucoma on the number of glaucoma surgeries.
    van der Valk R; Schouten JS; Webers CA; Beckers HJ; van Amelsvoort LG; Schouten HJ; Hendrikse F; Prins MH
    J Glaucoma; 2005 Jun; 14(3):239-42. PubMed ID: 15870608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient persistency with pharmacotherapy in the management of glaucoma.
    Reardon G; Schwartz GF; Mozaffari E
    Eur J Ophthalmol; 2003 Jul; 13 Suppl 4():S44-52. PubMed ID: 12948052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I; Harris A; Kagemann L; Siesky B; McCranor L
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics.
    Quaranta L; Biagioli E; Galli F; Poli D; Rulli E; Riva I; Hollander L; Katsanos A; Longo A; Uva MG; Torri V; Weinreb RN
    Adv Ther; 2016 Aug; 33(8):1305-15. PubMed ID: 27312975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: Strategies, clinical outcomes, and costs at 2 years.
    Rouland JF; Le Pen C; Benhaddi H; Piriou E; Lilliu H; Kenigsberg PA;
    Eur J Ophthalmol; 2005; 15(5):562-80. PubMed ID: 16167287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.